Flomerics Group PLC
17 August 2006
Flomerics Group plc (the "Company")
Holding in Company
Pursuant to rule 17, the Company has today been notfied of the following
interest in the Company's Ordinary 1p shares ("Shares").:
Schedule Five
(a) the identity of the director concerned;
Gary Carter
(b) the date on which the disclosure was made to it;
17 August 2006
(c) the date on which the deal or relevant change to the holding was effected;
17 August 2006
(d) the price, amount and class of the AIM securities concerned;
12,000 ordinary shares at 86.5 pence per share
(e) the nature of the transaction;
Purchase of shares by director
(f) the nature and extent of the directors's interest in the transaction;
Holding following the transaction
Gary Carter 20,000 0.1%
(g) where a deal takes place when it is in any close period under rule 21, the
date upon which any previous binding commitment was notified or the date upon
which the Exchange granted permission to deal in order to mitigate severe
personal hardship; and
N/A
(h) where the notification concerns a related financial product, the detailed
nature of the exposure.
N/A
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.